Themis Medicare

Price chart

Previous close

₹100.58

Open

₹101.00

Day high

₹105.89

Day low

₹101.00

Listed on NSE since 2 April 2007.

Market value

₹934.22 Cr

P/E (trailing)

23.23

EPS (trailing)

₹4.33

Price to book

2.34

Dividend yield

0.49%

Debt to equity

0.25

Profit margin

12.1%

Beta

0.67

Volume today

39,428

Average volume

2.26 L

Source: Yahoo Finance. Ratios use the latest reported (trailing twelve-month) figures.

Source: Yahoo Finance, from annual reports. Consolidated where reported.

Source: Themis Medicare’s results filed with NSE, consolidated (the whole group). Net profit is the share of Themis Medicare’s own shareholders where the filing separates it. Profit vs year ago compares with the same quarter a year earlier; – where that quarter is not on file or made a loss.

Download results (zip) A spreadsheet of the quarterly results and balance sheets, with the original filings from NSE.

Source: Themis Medicare’s half-yearly statements of assets and liabilities filed with NSE, consolidated. Companies file these every September and March.

Themis Medicare Limited, together with its subsidiaries, manufactures and sells pharmaceutical products in India and internationally. It provides active pharmaceutical ingredients (APIs) and formulations used in various therapeutic areas, including analgesic and anti-inflammatory, analgesic and antispasmodic, analgesics, anesthesia, antacid-antiflatulent, anti-fungal, antibiotic, anti-diabetic, anti-emetic, anti-hypertensive, anti-allergic and anti-inflammatory, anti-allergic and appetite stimulant, anticoagulant, antifibrolytic, antimalarial, anti-muscarinic, antioxidant, calcium, cardiovascular, corticosteroid, electrolytes, expectorant, haematinic, hemostatic agent, hemostatic agent with anesthetic, hormones, immunomodulator with anti-viral, muscle relaxant, narcotic analgesic, neuropathy, nutraceuticals, PPI, probiotic, reversal for muscle relaxant, sedatives, skeletal muscle relaxant, skeletal muscle relaxant and analgesic and anti-inflammatory, vasopressors, vitamins, and weight management. The company was formerly known as Themis Chemicals and changed its name to Themis Medicare Limited in 2001. Themis Medicare Limited was founded in 1952 and is headquartered in Mumbai, India.

Industry

Drug Manufacturers - Specialty & Generic

Based in

Mumbai

Employees

1,340

Company website · Profile: Yahoo Finance

No headlines name Themis Medicare in the last day or two.

• Dividend - Re 0.50 Per Share

  Dividend · ex-date 23 September 2026

• Dividend - Re 0.50 Per Share

  Dividend · ex-date 4 September 2025 · record date 5 September 2025

• Annual General Meeting/Dividend - Rs 0.50 Per Share

  Dividend · ex-date 12 July 2024

• Face Value Split (Sub-Division) - From Rs 10/- Per Share To Re 1/- Per Share

  Split · ex-date 10 October 2023

• Annual General Meeting/Dividend - Rs 5 Per Share

  Dividend · ex-date 1 September 2023

• Annual General Meeting/Dividend - Rs 5 Per Share

  Dividend · ex-date 8 September 2022

• Annual General Meeting/Dividend - Rs 4.30 Per Share

  Dividend · ex-date 8 September 2021

• Annual General Meeting/Dividend - Rs 1.75 Per Share

  Dividend · ex-date 17 September 2020

Source: NSE. Latest first, 8 of 20.